Historique
Bulletin de Périodique
Addiction , Vol.121, n°9 - September 2026
Paru le :
01/09/2026
Année
2026
Page(s) :
2269-2583
Langue(s) :
Anglais
Discipline :
SOM (Sommaire de périodique / Journal contents)
Note de contenu :
CONTENTS:
- The Baltics: Benchmarking alcohol control reform for the European Union and surrounding countries [Editorial]. Rehm J., Correia D., Lange S., Miscikiene L., Stelemekas M., p. 2272-2274.
- A call for action: Closing the evidence gap in management of stimulant-induced psychosis [Addiction opinion and debate]. Bouthillier A., Sharafi H., Bisaga A., Jutras-Aswad D., p. 2275-2283.
- Holistic approach to substance-induced psychosis. Lappin J.M., Darke S., Farrell M., p. 2284-2285.
- Stimulant-induced psychosis requires the same clinical priority as other psychotic disorders. Niemelä S., p. 2286-2287.
- Keeping stimulant-induced psychosis in sight. Arunogiri S., p. 2288-2289.
- Toward a public health and prevention-oriented approach to stimulant-induced psychosis. Bouthillier A., Sharafi H., Bisaga A., Jutras-Aswad D., p. 2290-2291.
- Patient-reported outcomes for monitoring substance use treatment: A systematic review of single-item measures. Reese T.J., Tindle H.A., Bachmann J., Wright A., Ancker J.S., Audet C.M., et al., p. 2292-2316.
- Evaluating comparative effect of non-pharmacological interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analysis. Lv B., Zhang Y.X., Tao Q.F., Lin L., Li X.Y., Chen B.Z., et al., p. 2317-2329.
- Predictive validity of Alcohol Use Disorder Identification Test - Consumption (AUDIT-C) for register-based alcohol-attributable events among general-population men and women of different ages. Mäkelä P., Reinikainen J., Callinan S., Jääskeläinen M., Kuurne K., Lintonen T., et al., p. 2330-2340.
- Health and economic impact of universal screening and management of alcohol use disorders in India: An economic modelling study. Purohit N., Singh S., Ambekar A., Duseja A., Mishra A.K., Rao G.N., et al., p. 2341-2352.
- Day-level associations between protective behavioral strategies and alcohol consequences among young adults enrolled vs. not enrolled in college. Shoemaker S.D., DiBello A.M., Freeman L., Merrill J.E., Carey K.B., Curtis A.F., et al., p. 2353-2361.
- Evaluating the immediate impacts of the repeal of the Northern Territory minimum unit price on off-premises alcohol pricing: Findings from an observational study of online alcohol retailers. Miller M., Man N., Taylor N., Livingston M., Clifford S., Kowalski M., et al., p. 2362-2372.
- Early insights from a national scheme providing vaping devices for smoking cessation: A preliminary evaluation to inform future return-on-investment modelling in England. Moore E., Gillespie D., Simonavicius E., Brose L., p. 2373-2383.
- Cost-effectiveness of in-hospital motivational smoking cessation counselling and proactive referral to community-based follow-up. Pleym K., Engebretsen I., Sverre E., Dammen T., Huseby E., Kahlon M.S., et al., p. 2384-2395.
- #NoIDVape: A content analysis of illicit vape messaging in young people's information sources. Bray E., Gentry S., Varley A., Notley C., Webb S., Ward E., p. 2396-2413.
- Context, mechanisms and outcomes of a social enterprise model of residential rehabilitation for problem substance use: A realist-informed process evaluation. Anderson M., Pickering L., McCann M., p. 2414-2423.
- Self-harm in individuals with substance use disorders: Predictive factors and risk model. Yu R., Tracy D.K., Sinclair J., Brikell I., Lichtenstein P., Larsson H., et al., p. 2424-2432.
- The feasibility of mindfulness-based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial. Ting K.T., Leung I.C.H., Chan D.C.C., Yu K.O.T., Tang W.K., Chan F., et al., p. 2433-2449.
- Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States. Tiyyala V.M., Dubois C., Madar C., Vandrey R., Thrul J., Dredze M., et al., p. 2450-2456.
- Association between state-level kratom regulations and poison center-reported severe medical outcomes and healthcare use: A United States national analysis. Comstock G., Gulotta A.P., Rein L.E., Feldman R., p. 2457-2467.
- Commentary on Comstock et al.: Here we go again-Kratom and the failure to learn from the opioid crisis. Kolodny A., p. 2468-2469.
- Drug sellers' use of a drug checking service amid the overdose crisis in British Columbia, Canada. Gonzalez-Nieto P., Wallace B., Kielty C., Shkolnikov I., Margolese A., Arredondo Sanchez Lira J., et al., p. 2470-2481.
- The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities Study. Walley A.Y., Cheng D.M., Vandergrift N., Larochelle M., Holloway J., Brown J.L., et al., p. 2482-2493.
- 'If you've ever experienced it, you'd feel differently': Exploring willingness and skepticism toward using higher dose naloxone products among people who use drugs in Maryland, United States. Sisson L.N., Rousch R.S., Hill L.G., Zagorski C.M., Triece T., Rouhani S., et al., p. 2494-2503.
- Substance-related intrusive memories in cocaine use disorder are different from but associated with craving. Zacher A., Dietiker L., Häffner V., Bavato F., Kleim B., Quednow B.B., p. 2504-2517.
- Commentary on Zacher et al.: How cocaine memories may drive craving and drug instrumentalization. Müller C.P., p. 2518-2519.
- Are people who use methamphetamine at increased risk of physical violence? Results from a nationally representative sample. Macdonald C., McKetin R., Alexeev S., Weatherburn D., p. 2520-2531.
- 'Emptiness filled with love': A reflexive thematic analysis of chemsex trajectories among gay, bisexual and other men who have sex with men in Almaty, Kazakhstan, using a life course framework. Lunchenkov N., Cherchenko N., German E., Rinne-Wolf S., p. 2532-2544.
- Characteristics of deaths due to drug-related causes among individuals recently released from prison in the United Kingdom, 1997-2025. Roberts E., Strang J., Copeland C., p. 2545-2551.
- Charting the decline of the fourth wave: US overdose deaths by race, ethnicity and substance involvement. Friedman J.R., Palamar J.J., Ciccarone D., Gaines T.L., Borquez A., Shover C.L., et al., p. 2552-2558.
- Commentary on Friedman et al.: Inequitable improvements and data gaps-A call for better drug surveillance data. Kiang M.V., p. 2559-2560.
- The evolution of Australian cannabis policies, 1967 to 2024. Hall W.D., Dawson D., Johnson B., Yimer T.M., p. 2561-2572.
- Beyond treatment response: Injection-site reactions as part of the extended-release buprenorphine experience. Cabé J., Brousse G., p. 2575-2576.
- Online prize draws and competitions: Gambling products outside the United Kingdom regulatory framework. McGarrigle J., Torrance J., Quigley M., Dymond S., p. 2577-2578.
- The Baltics: Benchmarking alcohol control reform for the European Union and surrounding countries [Editorial]. Rehm J., Correia D., Lange S., Miscikiene L., Stelemekas M., p. 2272-2274.
- A call for action: Closing the evidence gap in management of stimulant-induced psychosis [Addiction opinion and debate]. Bouthillier A., Sharafi H., Bisaga A., Jutras-Aswad D., p. 2275-2283.
- Holistic approach to substance-induced psychosis. Lappin J.M., Darke S., Farrell M., p. 2284-2285.
- Stimulant-induced psychosis requires the same clinical priority as other psychotic disorders. Niemelä S., p. 2286-2287.
- Keeping stimulant-induced psychosis in sight. Arunogiri S., p. 2288-2289.
- Toward a public health and prevention-oriented approach to stimulant-induced psychosis. Bouthillier A., Sharafi H., Bisaga A., Jutras-Aswad D., p. 2290-2291.
- Patient-reported outcomes for monitoring substance use treatment: A systematic review of single-item measures. Reese T.J., Tindle H.A., Bachmann J., Wright A., Ancker J.S., Audet C.M., et al., p. 2292-2316.
- Evaluating comparative effect of non-pharmacological interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analysis. Lv B., Zhang Y.X., Tao Q.F., Lin L., Li X.Y., Chen B.Z., et al., p. 2317-2329.
- Predictive validity of Alcohol Use Disorder Identification Test - Consumption (AUDIT-C) for register-based alcohol-attributable events among general-population men and women of different ages. Mäkelä P., Reinikainen J., Callinan S., Jääskeläinen M., Kuurne K., Lintonen T., et al., p. 2330-2340.
- Health and economic impact of universal screening and management of alcohol use disorders in India: An economic modelling study. Purohit N., Singh S., Ambekar A., Duseja A., Mishra A.K., Rao G.N., et al., p. 2341-2352.
- Day-level associations between protective behavioral strategies and alcohol consequences among young adults enrolled vs. not enrolled in college. Shoemaker S.D., DiBello A.M., Freeman L., Merrill J.E., Carey K.B., Curtis A.F., et al., p. 2353-2361.
- Evaluating the immediate impacts of the repeal of the Northern Territory minimum unit price on off-premises alcohol pricing: Findings from an observational study of online alcohol retailers. Miller M., Man N., Taylor N., Livingston M., Clifford S., Kowalski M., et al., p. 2362-2372.
- Early insights from a national scheme providing vaping devices for smoking cessation: A preliminary evaluation to inform future return-on-investment modelling in England. Moore E., Gillespie D., Simonavicius E., Brose L., p. 2373-2383.
- Cost-effectiveness of in-hospital motivational smoking cessation counselling and proactive referral to community-based follow-up. Pleym K., Engebretsen I., Sverre E., Dammen T., Huseby E., Kahlon M.S., et al., p. 2384-2395.
- #NoIDVape: A content analysis of illicit vape messaging in young people's information sources. Bray E., Gentry S., Varley A., Notley C., Webb S., Ward E., p. 2396-2413.
- Context, mechanisms and outcomes of a social enterprise model of residential rehabilitation for problem substance use: A realist-informed process evaluation. Anderson M., Pickering L., McCann M., p. 2414-2423.
- Self-harm in individuals with substance use disorders: Predictive factors and risk model. Yu R., Tracy D.K., Sinclair J., Brikell I., Lichtenstein P., Larsson H., et al., p. 2424-2432.
- The feasibility of mindfulness-based relapse prevention for adults with substance use disorders (illicit drugs) in a Chinese population: A pilot randomized controlled trial. Ting K.T., Leung I.C.H., Chan D.C.C., Yu K.O.T., Tang W.K., Chan F., et al., p. 2433-2449.
- Characterizing public comments via Regulations.gov in response to proposed cannabis rescheduling in the United States. Tiyyala V.M., Dubois C., Madar C., Vandrey R., Thrul J., Dredze M., et al., p. 2450-2456.
- Association between state-level kratom regulations and poison center-reported severe medical outcomes and healthcare use: A United States national analysis. Comstock G., Gulotta A.P., Rein L.E., Feldman R., p. 2457-2467.
- Commentary on Comstock et al.: Here we go again-Kratom and the failure to learn from the opioid crisis. Kolodny A., p. 2468-2469.
- Drug sellers' use of a drug checking service amid the overdose crisis in British Columbia, Canada. Gonzalez-Nieto P., Wallace B., Kielty C., Shkolnikov I., Margolese A., Arredondo Sanchez Lira J., et al., p. 2470-2481.
- The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities Study. Walley A.Y., Cheng D.M., Vandergrift N., Larochelle M., Holloway J., Brown J.L., et al., p. 2482-2493.
- 'If you've ever experienced it, you'd feel differently': Exploring willingness and skepticism toward using higher dose naloxone products among people who use drugs in Maryland, United States. Sisson L.N., Rousch R.S., Hill L.G., Zagorski C.M., Triece T., Rouhani S., et al., p. 2494-2503.
- Substance-related intrusive memories in cocaine use disorder are different from but associated with craving. Zacher A., Dietiker L., Häffner V., Bavato F., Kleim B., Quednow B.B., p. 2504-2517.
- Commentary on Zacher et al.: How cocaine memories may drive craving and drug instrumentalization. Müller C.P., p. 2518-2519.
- Are people who use methamphetamine at increased risk of physical violence? Results from a nationally representative sample. Macdonald C., McKetin R., Alexeev S., Weatherburn D., p. 2520-2531.
- 'Emptiness filled with love': A reflexive thematic analysis of chemsex trajectories among gay, bisexual and other men who have sex with men in Almaty, Kazakhstan, using a life course framework. Lunchenkov N., Cherchenko N., German E., Rinne-Wolf S., p. 2532-2544.
- Characteristics of deaths due to drug-related causes among individuals recently released from prison in the United Kingdom, 1997-2025. Roberts E., Strang J., Copeland C., p. 2545-2551.
- Charting the decline of the fourth wave: US overdose deaths by race, ethnicity and substance involvement. Friedman J.R., Palamar J.J., Ciccarone D., Gaines T.L., Borquez A., Shover C.L., et al., p. 2552-2558.
- Commentary on Friedman et al.: Inequitable improvements and data gaps-A call for better drug surveillance data. Kiang M.V., p. 2559-2560.
- The evolution of Australian cannabis policies, 1967 to 2024. Hall W.D., Dawson D., Johnson B., Yimer T.M., p. 2561-2572.
- Beyond treatment response: Injection-site reactions as part of the extended-release buprenorphine experience. Cabé J., Brousse G., p. 2575-2576.
- Online prize draws and competitions: Gambling products outside the United Kingdom regulatory framework. McGarrigle J., Torrance J., Quigley M., Dymond S., p. 2577-2578.
Cote :
Abonnement numérique
Dépouillements
Ajouter le résultat à votre sélection
Nouveauté
B. LV ;
Y. X. ZHANG ;
Q. F. TAO ;
L. LIN ;
X. Y. LI ;
B. Z. CHEN ;
H. ZHENG
|
2026
Dans Addiction (Vol.121, n°9, September 2026) Article : Périodique
Dans Addiction (Vol.121, n°9, September 2026) Article : Périodique
BACKGROUND AND AIMS: Non-pharmacological therapies are critical for disease management, particularly when pharmacological approaches are limited. Investigating their role as adjuncts to pharmacotherapy to improve outcomes in opioid use disorder [...]
Nouveauté
E. ROBERTS ;
J. STRANG ;
C. COPELAND
|
2026
Dans Addiction (Vol.121, n°9, September 2026) Article : Périodique
Dans Addiction (Vol.121, n°9, September 2026) Article : Périodique
BACKGROUND AND AIMS: There has been an extensive literature describing the elevated risk of drug-related death following an individual's release from prison; however, few previous studies have reported nationally representative samples or provid[...]